Champions Oncology (CSBR) Reports Q1 EPS of $0.05

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. WCN
6. SPOT
7. BMY
8. SPY
9. FIX
10. TSCO

Go back to Champions Oncology (CSBR) Reports Q1 EPS of $0.05

Champions Oncology Reports Record Quarterly Revenue of $6.2 Million

September 13, 2018 4:05 PM EDT

HACKENSACK, N.J., Sept. 13, 2018 /PRNewswire/ -- Champions Oncology, Inc. (Nasdaq: CSBR), engaged in an end-to-end range of research and development technology solutions and services to improve the development and use of oncology drugs, today announced its financial results for the first fiscal quarter ended July 31, 2018.

First Quarter and Recent Business Highlights:

Record quarterly revenue of $6.2 million, an increase of 23.7% year-over-year Record net income of $482,000, including stock-based compensation and depreciation Granted Full Accreditation by the Association for Assessment and Accreditation of Laboratory... More